GoKawiilAngle Health raises $200M Series C at $2.7B valuation
Angle Health, a Y Combinator alum from 2020 that helps small businesses manage level-funded health plans, announced a $200 million Series C round plus a $400 million tender offer allowing employees to sell shares. The round, valuing the company at $2.7 billion, was led by Vitruvian Partners with participation from Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator, and is expected to close later this month. Angle says it now serves over 5,000 businesses and is profitable.
GoKawiil's interpretation of the reporting above, not reported fact.
Large Series C rounds for non-AI startups founded before the current funding boom have become unusual, making this deal notable as a sign that investors still see value in insurance technology addressing small-business affordability. The tender offer also signals confidence in long-term growth, giving early employees liquidity without forcing an IPO or acquisition.
- Angle Health raised $200M at a $2.7B valuation plus a $400M tender offer for employees.
- The startup helps small businesses manage level-funded health insurance plans, blending predictability with potential savings.
- It's a rare large raise for a company founded in 2019 that isn't focused on AI agents, though it does use AI in its platform.
Source: techcrunch.com — Julie Bort, 2026-09-18
Published there as: “Y Combinator insurance tech alum Angle Health hits $2.7B valuation”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.